Search clinical trials for: ß2-adrenergic agonist,

Total 1157 results

National Science Council, Taiwan

Completed

Melatonin Receptor Agonist and Peripheral Biological Markers

Insomnia
University of Rochester

Completed

Brain Effects of Opiate Agonist and Antagonist

Chronic Low-back Pain

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Combining Behavioral Treatment With Agonist Maintenance - 1

Substance-Related Disorders | Opioid-Related Disorders | Cocaine-Related Disorders

United States
Mt. Hope Maternity Hospital

Completed

Gonadotropin-releasing Hormone Agonist Prior to Myomectomy

Fibroids

Trinidad and Tobago
Cubist Pharmaceuticals LLC

Completed

Analgesic Efficacy and Safety of ADL5859 in Subjects With Acute Dental Pain After Third Molar Extraction

Acute Pain

United States
Henri Mondor University Hospital
Paris 12 Val de Marne University

Completed

Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety.

Immune Thrombocytopenia | Thrombopoietin Receptor Agonist
Terns, Inc.

Completed

DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis

NASH - Nonalcoholic Steatohepatitis

United States
Embryolab Fertility Clinic
ART Fertility Clinics LLC

Recruiting

The Effect of Dual Trigger (GnRH Agonist + hCG) for Final Maturation in Oocyte Donors With History of a Previous Cycle With Suboptimal Response to GnRH Agonist Only Trigger

Ovarian Stimulation | Oocyte Donors | Human Chorionic Gonadotropin

Greece
Zealand Pharma

Completed

A Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

Healthy

Germany
Beijing Dongfang Biotech Co., Ltd.

Unknown

a Study of JY09 in Chinese Healthy Subjects

Healthy
Roswell Park Cancer Institute
National Cancer Institute (NCI); Cleveland BioLabs, Inc.

Withdrawn

Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy

Mucositis | Tongue Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx | Recurrent Squamous Cell Carcinoma of the Paranasal... and other conditions
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Starting Treatment With Agonist Replacement Therapies (START)

Opiate-related Disorders

United States
Zydus Lifesciences Limited

Completed

A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers (ZYD1)

Type 2 Diabetes Mellitus

India
Royan Institute

Completed

Repeated Doses of GnRH Agonist as Oocyte Triggering in Antagonist Protocol for Patients With Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Iran, Islamic Republic of
Sheba Medical Center

Unknown

Ultrashort GnRH Agonist/Antagonist Versus GnRH Antagonist IVF

Infertility

Israel
University Hospital, Strasbourg, France
EUCLID Clinical Trial Platform; NS-PARK; F-CRIN

Recruiting

Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease. (PIMPARK)

Parkinson Disease

France
University Hospital, Grenoble
Institut National de la Santé Et de la Recherche Médicale, France

Unknown

Apathy in Parkinson Disease: Clinical, Physiopathological and Pharmacological Study

Apathy in Parkinson Disease

France
Assistance Publique - Hôpitaux de Paris

Unknown

Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer (PRESOV)

Sarcoma | Lymphoma | Cancer | Osteosarcoma | Ewing Sarcoma | Toxicity Due to Chemotherapy

France
Odense University Hospital

Completed

FFAR Agonist on Incretins, Insulin, Lipids and Inflammation

Obesity | Type2 Diabetes Mellitus
Turku University Hospital

Completed

GnRH Agonist as Luteal Support in FET Cycles

Infertility
University of Colorado, Denver

Terminated

Phase I Nicotinic Agonist Treatment Trial for Autism

Autism

United States
King's College London

Recruiting

Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health

Obesity | Diabetes Mellitus | Mental Health Issue

United Kingdom
Azienda Ospedaliero-Universitaria Consorziale Policlinico...

Completed

Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes

Diabetes Mellitus, Type 2

Italy
Aristotle University Of Thessaloniki

Terminated

Duration of GnRH-analogue Downregulation and Pregnancy Rates

Infertility

Greece
Institute of Hematology & Blood Diseases Hospital
Henan Cancer Hospital; Nantong University; Tianjin Medical University Second... and other collaborators

Unknown

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

Primary Immune Thrombocytopenia (ITP)

China
Boston Children's Hospital
Children's Hospital Medical Center, Cincinnati

Recruiting

Skeletal Health and Bone Marrow Composition Among Youth

Puberty | Gender Dysphoria in Children | Bone Development

United States
Ascletis Pharmaceuticals Co., Ltd.

Completed

Study to Evaluate Safety, Tolerability and Pharmacokinetics of ASC42 in Chinese Healthy Subjects

Healthy

China
Centre Hospitalier Universitaire Ibn Rochd

Completed

GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT (GTMLPSGI)

Infertility

Algeria
Novartis

Completed

Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma

Asthma

United States
Novartis

Completed

26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Lung Diseases, Obstructive | Pulmonary Disease, Chronic Obstructive | COPD

United States, Germany, Spain, Argentina, Italy, Turkey, Canada, India, Sweden, Korea, Republic of, Taiwan, Puerto Rico
Kyoto University, Graduate School of Medicine
National Institute of Biomedical Innovation

Terminated

Therapeutic Study of ONO-4819CD for Ulcerative Colitis

Ulcerative Colitis

Japan
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Malignant Ovarian Mixed Epithelial Tumor | Ovarian Brenner Tumor | Ovarian Mucinous... and other conditions

United States
Ferring Pharmaceuticals

Completed

Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists. (ProComD)

Advanced Prostate Cancer

Germany
Emirates Health Services (EHS)

Recruiting

POSE2.0 With GLP-1 Agonist for Obesity Management

Obesity

United Arab Emirates
University of Colorado, Denver

Completed

Nicotinic Agonist Effects on BMI and Neuronal Response

Obesity

United States
Boston Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Benzodiazepine Discontinuation in Opioid Agonist Therapy (BZD-OAT)

Substance Use Disorders

United States
Maimonides Medical Center

Withdrawn

GnRH Agonist at Embryo Transfer: IVF Outcomes (GRAET)

Infertility | Infertility, Female | Infertility, Male

United States
Yale University

Completed

Testosterone Replacement for Male Opioid Agonist Maintained Patients

Chronic Pain | Opioid Addiction | Symptomatic Hypogonadism

United States
National Institute on Drug Abuse (NIDA)
Johns Hopkins University

Terminated

Opioid Agonist and Antagonist Effects on Opioid Dependence

Opioid-Related Disorders

United States
Elisha Hospital
Merck Sharp & Dohme LLC

Terminated

Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome?

Ovarian Hyperstimulation Syndrome

Israel
PregLem SA

Completed

PGL4001 Versus GnRH-agonist in Uterine Myomas (PEARLII)

Uterine Myomas

Spain, Germany, Austria, Israel, Poland, Italy, Belgium, France, Netherlands
VA Office of Research and Development

Recruiting

AIH for Spinal Cord Repair

SCI

United States
Cubist Pharmaceuticals LLC
Pfizer

Terminated

Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia

Postherpetic Neuralgia

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Mood Effects of Serotonin Agonists Extended (MESA-E)

Healthy

United States
Robert Lowsky
National Cancer Institute (NCI); Janssen, LP; The Leukemia and Lymphoma Society; Rising Tide Foundation

Completed

TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma

Mantle Cell Lymphoma | Marginal Zone Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma

United States
Global Health Drug Discovery Institute
CMAX Clinical Research Pty Limited; Avance Clinical

Completed

SAD Study of APR002 Investigating the Safety/Tolerability, Pharmacokinetics/Pharmacodynamics in Healthy Subjects

COVID-19

Australia
Hospital de Clinicas de Porto Alegre

Unknown

Evaluation of Granulosa Cells Function After IVF Protocols

Infertility | In Vitro Fertilization Protocols

Brazil
Cairo University

Completed

Endometrial Volume and Sub-endometrial Vascularity as Predictors of In-vitro Fertilization Success

Reproductive Techniques, Assisted
Joachim Aerts, MD PhD

Completed

MesoPher/Mitazalimab-combination Therapy in Metastatic Pancreatic Disease (REACtiVe-2 Trial) (REACtiVe-2)

Metastatic Pancreatic Cancer

Netherlands
St. Olavs Hospital
Norwegian University of Science and Technology

Recruiting

Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas

Adenoma | Pituitary Neoplasms

Norway, Sweden

Search clinical trials for: ß2-adrenergic agonist,

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations